A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Clinical trial NCT00502294 · WITHDRAWN
Trial details
- NCT number
- NCT00502294
- Sponsor
- Facet Biotech
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.